The North America Endovascular Aneurysm Repair Market is expected to witness market growth of 4.2% CAGR during the forecast period (2022-2028).
Endovascular aneurysm repair is a minimally invasive procedure that uses a specialized stent transplant known as an endograft. An aneurysm arises when the walls of the arteries become weaker, and the artery enlarges, much like a balloon, as the blood pressure beats against the weakening artery walls. An endovascular stent graft is placed in an aortic aneurysm to do this endovascular repair.
An aneurysm is a condition in which the artery wall enlarges due to weakness or deterioration. It is commonly linked to the use of tobacco and smoking. Aneurysms are also more common in those who have medical disorders including atherosclerosis, excessive cholesterol, or connective tissue illness. Endovascular aneurysm repair (EVAR) is a minimally invasive method or surgery for the repair of these aneurysms. The covered stent, a metal mesh tube with a coating of fabric, is inserted into the weak portion of the artery during the EVAR operation. This allows blood to circulate freely without pooling in the bulge, preventing it from exploding. Aneurysms can now be treated with a variety of technologies available on the market.
The U.S. government enacted the Screening Abdominal Aortic Aneurysms Very Efficiently (SAVE) Act in 2014, which provides one free AAA screening to men who have smoked at least once in their lives and women with a family history of the ailment. Furthermore, large government reimbursements in industrialized countries are another aspect boosting overall industry growth. In the United States, for example, Medicare provides one abdominal aortic ultrasound for patients at risk. The National Health Service (NHS) and the United States Food and Drug Administration (FDA) are attempting to reduce the occurrence of aortic aneurysm.
The US market dominated the North America Endovascular Aneurysm Repair Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $963.5 million by 2028. The Canada market is anticipated to grow at CAGR of 6.5% during (2022-2028). Additionally, The Mexico market is expected to showcase a CAGR of 5.6% during (2022-2028).
Based on Indication, the market is segmented into Abdominal and Thoratic. Based on Product, the market is segmented into Percutaneous Evar, Fenestrated Evar, Aortic Stents & Taa Graft, and Others. Based on Site, the market is segmented into Infrarenal and Pararenal. Based on Anatomy, the market is segmented into Traditional and Complex. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Endologix LLC, Lombard Medical Limited, Cardinal Health, Inc., Becton, Dickinson and Company, Medtronic PLC, Cook Medical, Inc., Koninklijke Philips N.V., Terumo Corporation, Abbott Laboratories, and Artivion, Inc.
By Indication
By Country
Endovascular aneurysm repair is a minimally invasive procedure that uses a specialized stent transplant known as an endograft. An aneurysm arises when the walls of the arteries become weaker, and the artery enlarges, much like a balloon, as the blood pressure beats against the weakening artery walls. An endovascular stent graft is placed in an aortic aneurysm to do this endovascular repair.
An aneurysm is a condition in which the artery wall enlarges due to weakness or deterioration. It is commonly linked to the use of tobacco and smoking. Aneurysms are also more common in those who have medical disorders including atherosclerosis, excessive cholesterol, or connective tissue illness. Endovascular aneurysm repair (EVAR) is a minimally invasive method or surgery for the repair of these aneurysms. The covered stent, a metal mesh tube with a coating of fabric, is inserted into the weak portion of the artery during the EVAR operation. This allows blood to circulate freely without pooling in the bulge, preventing it from exploding. Aneurysms can now be treated with a variety of technologies available on the market.
The U.S. government enacted the Screening Abdominal Aortic Aneurysms Very Efficiently (SAVE) Act in 2014, which provides one free AAA screening to men who have smoked at least once in their lives and women with a family history of the ailment. Furthermore, large government reimbursements in industrialized countries are another aspect boosting overall industry growth. In the United States, for example, Medicare provides one abdominal aortic ultrasound for patients at risk. The National Health Service (NHS) and the United States Food and Drug Administration (FDA) are attempting to reduce the occurrence of aortic aneurysm.
The US market dominated the North America Endovascular Aneurysm Repair Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $963.5 million by 2028. The Canada market is anticipated to grow at CAGR of 6.5% during (2022-2028). Additionally, The Mexico market is expected to showcase a CAGR of 5.6% during (2022-2028).
Based on Indication, the market is segmented into Abdominal and Thoratic. Based on Product, the market is segmented into Percutaneous Evar, Fenestrated Evar, Aortic Stents & Taa Graft, and Others. Based on Site, the market is segmented into Infrarenal and Pararenal. Based on Anatomy, the market is segmented into Traditional and Complex. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Endologix LLC, Lombard Medical Limited, Cardinal Health, Inc., Becton, Dickinson and Company, Medtronic PLC, Cook Medical, Inc., Koninklijke Philips N.V., Terumo Corporation, Abbott Laboratories, and Artivion, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Indication
- Abdominal
- Thoratic
- Percutaneous Evar
- Fenestrated Evar
- Aortic Stents & Taa Graft
- Others
- Infrarenal
- Pararenal
- Traditional
- Complex
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Endologix LLC
- Lombard Medical Limited
- Cardinal Health, Inc.
- Becton, Dickinson and Company
- Medtronic PLC
- Cook Medical, Inc.
- Koninklijke Philips N.V.
- Terumo Corporation
- Abbott Laboratories
- Artivion, Inc.
Unique Offerings from the Publisher
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 4. North America Endovascular Aneurysm Repair Market by Indication
Chapter 5. North America Endovascular Aneurysm Repair Market by Product
Chapter 6. North America Endovascular Aneurysm Repair Market by Site
Chapter 7. North America Endovascular Aneurysm Repair Market by Anatomy
Chapter 8. North America Endovascular Aneurysm Repair Market by Country
Chapter 9. Company Profiles
Companies Mentioned
- Endologix LLC
- Lombard Medical Limited
- Cardinal Health, Inc.
- Becton, Dickinson and Company
- Medtronic PLC
- Cook Medical, Inc.
- Koninklijke Philips N.V.
- Terumo Corporation
- Abbott Laboratories
- Artivion, Inc.
Methodology
LOADING...
